Abu-Sbeih, Hamzah; Ali, Faisal S.; Patel, Sandipkumar; Otterson, Gregory A.; Kendra, Kari; Ricciuti, Biagio; Chiari, Rita; De Giglio, Andrea; Sleiman, Joseph; Funchain, Pauline; Wills, Beatriz; Zhang, Jiajia; Naidoo, Jarushka; Philpott, Jessica; Gao, Jianjun; Subudhi, Sumit K.; Wang, Yinghong (2019-10-20)
PURPOSE: Immune checkpoint inhibitor (ICI) therapy often is suspended because of immune-mediated diarrhea
and colitis (IMDC). We examined the rate of and risk factors for IMDC recurrence after ICI resumption.
METHODS: ...
